Latest Corporate News

Pharmascience Canada Launches pms-DIMETHYL FUMARATE for the Treatment of Relapsing Remitting Multiple Sclerosis!

Read more

Pharmascience Inc. has officially formalized the acquisition of its business partner’s shares in South Korea

Read more

PHARMASCIENCE RECEIVES STANDARD PROCESSING LICENCE FROM HEALTH CANADA

Read more

PHARMASCIENCE INC. LAUNCHES PMS-FLUTICASONE HFA 250mcg FOR THE TREATMENT OF STEROID-RESPONSIVE BRONCHIAL ASTHMA IN ADULTS AND CHILDREN

Read more

Brochure

MORE THAN 30 YEARS OF GROWTH AND STRENGTH

Our Commitment

LEARN MORE ABOUT OUR QUALITY PRODUCTS AND SUPPLY